Edison have increased their VLA target price, page-4

Ye of little faith ST. Things tend to happen very quickly in this space, at least if you're watching them rather than holding. If you're holding probably nothing ever happens. Never mind.

There does seem to be real momentum building in the stock even though the price is rangebound. Doesn't seem to be any local coverage apart from Bell Potter but I have heard non-related biotech folk speak well of them. Roth and Edison seem to show the eyes of big pharma are upon them.

Is this a space you want to be in? There are a few biotechs that work out well for taking up issues and selling into news, including VLA, but for pure traders it probably requires too much patience.